Etoposide or alkylating agents should get complete blood counts (CBCs) yearly for evidence of myelodysplasia or a secondary leukemia.
依托泊苷者烷化剂的治疗应该每年接受全
细胞计
检查,以监测骨髓发育不良
继发性白
病的发生迹象。
Etoposide or alkylating agents should get complete blood counts (CBCs) yearly for evidence of myelodysplasia or a secondary leukemia.
依托泊苷者烷化剂的治疗应该每年接受全
细胞计
检查,以监测骨髓发育不良
继发性白
病的发生迹象。
We find that unqualified specimen because of poor quality control of preanalysis account for 9 40%.of total complete blood count specimen.
40%,其中因临床标本采集和运输不当造成的标本质量问题占72。
声明:以上例句、词性分类均由互联网动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
Etoposide or alkylating agents should get complete blood counts (CBCs) yearly for evidence of myelodysplasia or a secondary leukemia.
依托泊苷者烷化剂的治疗应该每年接受全血细胞
查,以监测骨髓发育不良
继发性白血病的发生迹
。
We find that unqualified specimen because of poor quality control of preanalysis account for 9 40%.of total complete blood count specimen.
40%,因临床标本采集和运输不当造成的标本质量问题占72。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
Etoposide or alkylating agents should get complete blood counts (CBCs) yearly for evidence of myelodysplasia or a secondary leukemia.
依托泊苷者烷化剂的治疗应该每年接受全
细胞计数检查,以监测
育不良
继
性
的
生迹象。
We find that unqualified specimen because of poor quality control of preanalysis account for 9 40%.of total complete blood count specimen.
40%,其中因临床标本采集和运输不当造成的标本质量问题占72。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若现问题,欢迎向我们指正。
Etoposide or alkylating agents should get complete blood counts (CBCs) yearly for evidence of myelodysplasia or a secondary leukemia.
泊苷
者烷化剂的治疗应该每年接受全血细胞计数检查,以监测骨髓发育不良
继发性白血病的发生迹象。
We find that unqualified specimen because of poor quality control of preanalysis account for 9 40%.of total complete blood count specimen.
40%,其中因临床标本采集和运输不当造成的标本质量问72。
明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问
,欢迎向我们指正。
Etoposide or alkylating agents should get complete blood counts (CBCs) yearly for evidence of myelodysplasia or a secondary leukemia.
依托泊苷者烷化剂的治疗应该每年接受
细胞计数检查,以监测骨髓发育不良
继发性白
病的发
迹象。
We find that unqualified specimen because of poor quality control of preanalysis account for 9 40%.of total complete blood count specimen.
40%,其中因临床标本采集和运输不当造成的标本质量问题占72。
声明:以上例句、词性分类均由互联网资源成,
分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
Etoposide or alkylating agents should get complete blood counts (CBCs) yearly for evidence of myelodysplasia or a secondary leukemia.
依托泊苷者烷化剂的治疗应该每年接受全血细胞计数检查,以监测骨髓发育不良
继发
白血病的发生迹象。
We find that unqualified specimen because of poor quality control of preanalysis account for 9 40%.of total complete blood count specimen.
40%,其中因临床标本采集和运输不当造成的标本质量问题占72。
声明:以上例句、词均由互联网资源自动生成,部
未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
Etoposide or alkylating agents should get complete blood counts (CBCs) yearly for evidence of myelodysplasia or a secondary leukemia.
依托泊苷者烷化剂的治疗应该
受全血细胞计数检查,以监测骨髓发育不良
继发性白血病的发生迹象。
We find that unqualified specimen because of poor quality control of preanalysis account for 9 40%.of total complete blood count specimen.
40%,其中因临床标本运输不当造成的标本质量问题占72。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
Etoposide or alkylating agents should get complete blood counts (CBCs) yearly for evidence of myelodysplasia or a secondary leukemia.
依托泊苷者烷化剂
治疗应该每年接受全血细胞计数检查,以
髓
育不良
继
性白血
生迹象。
We find that unqualified specimen because of poor quality control of preanalysis account for 9 40%.of total complete blood count specimen.
40%,其中因临床标本采集和运输不当造成标本质量问题占72。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件观点;若
现问题,欢迎向我们指正。
Etoposide or alkylating agents should get complete blood counts (CBCs) yearly for evidence of myelodysplasia or a secondary leukemia.
依托泊苷者烷化剂的治疗应该每年接受全血细胞计数检查,以监测骨髓发育不良
继发
白血病的发生迹象。
We find that unqualified specimen because of poor quality control of preanalysis account for 9 40%.of total complete blood count specimen.
40%,其中因临床标本采集和运输不当造成的标本质量问题占72。
声明:以上例、词
分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。